Regeneron Pharmaceuticals | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 4.81B 1.54B 2024-12
Agios Pharmaceuticals USD -105399000 1.11B 2024-12
Alnylam Pharmaceuticals USD -193958000 85.3M 2024-12
Amgen USD 3.38B 111M 2024-12
Astellas Pharma JPY -118359000000 156.91B 2024-12
AstraZeneca USD 1.67B 162M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 4.26B 226M 2024-12
Eli Lilly USD 5.54B 3.83B 2024-12
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 563M 2.08B 2024-12
Incyte USD 406.83M 147.12M 2024-12
Ionis Pharmaceuticals USD -107000000 37M 2024-12
J&J USD 5.42B 1.86B 2024-12
Kyowa Hakko Kirin JPY 25.05B 3.37B 2024-09
Merck USD 5.22B 114M 2024-12
Moderna USD -1184000000 1.2B 2024-12
Neurocrine Biosciences USD 162.6M 27.7M 2024-12
Novartis USD 4.66B 269M 2024-12
Novartis USD 4.66B 269M 2024-12
Opthea AUD -128431000 27.21M 2024-06
Pfizer USD 4.44B 2.36B 2024-12
Regeneron Pharmaceuticals USD 958.1M 534.9M 2024-12
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi USD 2.32B 2.64B 2024-12
Sarepta Therapeutics USD 171.74M 137.74M 2024-12
Teva Pharmaceutical Industries USD 899M 1.22B 2024-12
Ultragenyx Pharmaceutical USD -133404000 191K 2024-12
United Therapeutics USD 396.5M 7.9M 2024-12
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12



Regeneron Pharmaceuticals Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2025.